Intravenous ketoprofen for severe lithium-induced polyuria;Traitement par kétoprofène intraveineux d'une polyurie sévère survenue au cours d'une intoxication au lithium

Presse Medicale

Volumn 34, Issue 16 I, 2005, Pages 1137-1140

  Tran Van, David ^a   Avargues, P ^a   Labadie, P ^a   Herve Y ^a   Dardare, E ^a   Fontaine, B ^a  

^a HÔPITAL D'INSTRUCTION DES ARMÉES ROBERT PICQUÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

KETOPROFEN; LITHIUM;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; HUMAN; INTOXICATION; LITHIUM BLOOD LEVEL; LONG TERM CARE; MALE; NEUROLOGIC DISEASE; POLYURIA; RENAL DIABETES;

EID: 25444518765     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(05)84137-5     Document Type: Article

References (20)

1. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfonction associated with chronique lithium therapy. Am J Kidney Dis 1987; 10: 329-45.
2. Mac Gregor DA, Baker AM, Appel RG, Ober KP, Zaloga GP. Hyperosmolar coma due to lithium-induced diabetes insipidus. Lancet 1995; 346: 413-17.
3. Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S. Lithium induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest 1995; 95: 1838-45.
4. 2, cAMP and vasopressin in lithium-induced polyuria. Am J Physiol 1988; 254: R863-9.
5. Breyer MD, Jacobson HR, Breyer RM. Functional and molecular aspects of renal prostaglandin receptors. J Am Soc Nephrol 1996; 7: 8-17.
6. Diptarup M, Lingesan G, Kanthaya M. Lithium-induced nephrogenic diabetes insipidus in older people. Age and ageing 2001; 30: 347-50.
7. Meinardi JR, Donders SH. Nephrogenic diabetes insipidus in a lethargic lithium-treated patient. Neth J Med 1997; 50: 105-9.
8. Azam H, Newton RW, Morris AD, Thompson CJ. Hyperosmolar nonketotic coma precipitated by lithium-induced nephrogenic diabetes insipidus. Postgrad Med 1998; 74: 39-46.
9. Kamijo Y, Soma K, Hamanaka S, Nagai T, Kurihara K. Dural sinus thrombosis with severe hypernatremia developing in patient long-term lithium therapy. J Toxicol Clin Toxicol 2003; 41: 359-62.
10. Mac Gregor DA, Dolinski SY. Hyperosmolar coma. Lancet 1999; 353: 1189.
11. Friedman BC, Bekes CE, Scott WE, Bartter NJ. ARDS following acute lithium carbonate intoxication. Intensive Care Med 1992; 18: 123-4.
12. Kosten TR, Forrest JN. Treatment of severe lithium-induced polyuria with amiloride. Am J Psychiatry 1986; 143: 1563-8.
13. Batlle DC, Von Riotte AB, Gaviria M, Grupp M. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med 1985; 312: 408-14.
14. Waise A, Fisken RA. Unsuspected nephrogenic diabetes insipidus. BMJ 2001; 323: 96-7.
15. Wee PM, Van Hoek B, Donker AJ. Indomethacin treatment in a patient with lithium-induced polyuria. Intensive Care Med 1985; 11: 103-4.
16. Grindlinger GA, Boyland MJ. Amelioration by indomethacin of lithium-induced polyuria. Crit Care Med 1987; 15: 538-9.
17. Allen HM, Rhett LJ, Winchester MD, Deck LV, Allon M. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus. Arch Intern Med 1989; 149: 1123-6.
18. Martinez EJ, Sinnott JT, Rodriguez-Paz G, Oehler RL. Lithium-induced diabetes insipidus treated with indomethacin. South Med J 1993; 86: 971-3.
19. Lam SS, Kjellstrand C. Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs. Ren Fail 1997; 19: 183-8.
20. Burke C, Fulda G, Castellano J. Lithium-induced nephrogenic diabetes insipidus treated with intravenous ketorolac. Crit Care Med 1995; 23: 1924-7.